Development of a Novel Platelets Functional Assay Using QCM†
AbstractThrombocytes and their metabolites are involved in numerous physiological and pathophysiological processes, such as blood coagulation at the site of ruptured endothelium. Normal platelet aggregation can be suppressed via platelet antagonists or non-steroidal anti-inflammatory drugs (NSAIDs). That’s why differentiating between resting (“normal”) and inhibited platelets in a quick and precise fashion could be of a great clinical significance. Herein, we present the first step on the way to a novel platelet functionality assay based on Molecularly Imprinted Polymers (MIP) coated onto Quartz Crystal Microbalance (QCM). First results reveal sensor responses that depend on platelet concentration and on incubation of platelets with aspirin: acetyl salicylic acid (AAS).
Share & Cite This Article
Strallhofer, A.E.; Jung, S.; Jungbauer, C.; Lieberzeit, P.A. Development of a Novel Platelets Functional Assay Using QCM. Proceedings 2017, 1, 514.
Strallhofer AE, Jung S, Jungbauer C, Lieberzeit PA. Development of a Novel Platelets Functional Assay Using QCM. Proceedings. 2017; 1(4):514.Chicago/Turabian Style
Strallhofer, Agnieszka E.; Jung, Stefan; Jungbauer, Christof; Lieberzeit, Peter A. 2017. "Development of a Novel Platelets Functional Assay Using QCM." Proceedings 1, no. 4: 514.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.